Upload
ethelbert-greene
View
220
Download
0
Tags:
Embed Size (px)
Citation preview
Managing the “Older” PetCanine Cognitive Dysfunction
Managing the “Older” PetCanine Cognitive Dysfunction
Stephen Barabás BSc BVMS MRCVS1
1.VetPlus,Lytham St. Anne’s, UK
Agenda
The Geriatric PetCognitive Dysfunction Syndrome (CD)Epidemiological Surveys of Pet OwnersPatho-physiology of CDDiagnosisManagement and treatmentConclusion
Introduction CDS Epidemiology Pathology Management Conclusion
Geriatric AnimalsAudience Practising Vet Questions
How many good clients do you have attending your practice?
• 500• 1000• >2000
How many vets in this auditorium have >20% + of their clients pets >8 years old?
Are these clients loyal customers? Are they willing to spend money to help their “old
friend”? Is time and lifestyle a factor in their decision? Do there
pets get neglected in this busy world?
Introduction CDS Epidemiology Pathology Management Conclusion
Geriatric Animals
Dogs and Cats are living longer Dogs living for 12 + years Not uncommon for 20+ year old cat
Diseases become more similar to human aging population
Thyroid disorders Pituitary – adrenal gland disorders General organ system failure Cancer Cognitive Dysfunction Syndrome (CD)
Introduction CDS Epidemiology Pathology Management Conclusion
UK survey of dog owners in 2000
30% of the UK dogs were >8 years old
Owners expect pets to live >13 years
Increased expectation of healthcare and quality of life for older dogs and cats
Better Foods and supplements Better understanding of general health care Better drugs and vaccines
Introduction CDS Epidemiology Pathology Management Conclusion
“Nurturing Older Dogs: attitudes and experiences of caregivers”
Questionnaire of the caregivers in US old people’s homes of elderly dogs kept within their institutionsThe caregivers felt the older dogs were:
More mellow Less excitable More devotion and loving than younger dog
Rewards of Companionship >> Time and Expense of looking after an older dog
JAVMA 2001 – Hart et al
Introduction CDS Epidemiology Pathology Management Conclusion
Managing the Older Dog
Counselling of the owner is the most important factorHelp them understand the biological changes in health and behaviour of their aging pet
40% of owners with dogs 11-12 yrs old have visual impairment
50% of 11-12 yrs old and 90% of owners with dogs 15-16 yrs old had hearing impairment
• Hand signals, Jumping on the spot, tactile directions
Dental problems will increase with age – cleaning and brushing will prevent problems
Introduction CDS Epidemiology Pathology Management Conclusion
Managing the Older Dog
Adapt household to help arthritic animal Elevated food/water bowls Comfortable/Warm bedding Avoid slippery floors i.e. Rugs and Mats
Anxieties can increase resulting in behavioural changes with age
Separation anxiety House soiling Sleep-wake cycle problems
Canine and Feline Behavior Therapy 2nd Edition
Introduction CDS Epidemiology Pathology Management Conclusion
What is Cognitive Dysfunction?
“Cognitive Dysfunction is a syndrome associated with brain aging. The brain
changes lead to alterations in awareness, decreased responsiveness to stimuli, and deficits in learning and memory. Subtle
changes are seen in early stages, referred to as cognitive decline.”
Blackwell’s Five-Minute Veterinary ConsultCanine & Feline Behavior
Introduction CDS Epidemiology Pathology Management Conclusion
What is Cognitive Dysfunction?
Medical condition Compromised cerebral blood flow Depletion in neurotransmitters such as
dopamine Increased levels of free radicals
• Leading to cell injury and brain pathology
Main signs are Behavioural Disorientation
Loss of House Training Changes in Sleep Patterns Reduced Social Interaction
Ensure that a full clinical exam eliminates other causes of behavioural changes
Introduction CDS Epidemiology Pathology Management Conclusion
Clinical Signs of Cognitive Dysfunction
Disorientation
Interaction Reduction
Sleep Patterns Alterations
House Training LossActivity Level Reduction
An English acronym = DISHA
Introduction CDS Epidemiology Pathology Management Conclusion
Canine Cognitive Dysfunction (CD) incidence from USA Studies
“Most commonly affects dogs greater than 10 yrs old”
48% of dogs >7 yrs old62% of dogs 11-16 yrs old100% of dogs >15 yrs old
Showed one or more signs of Cognitive Dysfunction (CD)}
Introduction CDS Epidemiology Pathology Management Conclusion
“Prevalence of behavioural changes associated with age related cognitive
impairment in dogs”
Per
cent
Neilson et al JAVMA 2001
Introduction CDS Epidemiology Pathology Management Conclusion
Total Number of Surveys completed = 981
Average age of pets in the survey Dogs 11 years Cats 13 years Most people think one pet year is equivalent of
7 human years, therefore 9 year old animals are approaching “retirement age”
Crufts Survey of UK Pet Owners - pets over 7 years olds
Introduction CDS Epidemiology Pathology Management Conclusion
Dogs 80%
Cats 20%
Crufts Survey of UK Pet Owners - pets over 7 years olds
Questions asked about awareness of problems and treatments as well as clinical signs in their own pet
93% think that pets should get the same or better medical treatment than themselves
31% already giving supplements on a daily basis
Introduction CDS Epidemiology Pathology Management Conclusion
Compared to when the pets were younger:
Per
cent
of
pets
House
Soili
ng
House
Soili
ngD
isorie
ntat
ion
Diso
rient
atio
n
Inter
actio
n
Inter
actio
nSl
eep
Patter
ns
Slee
p Pat
terns
Qua
lity o
f Life
Qua
lity o
f Life
Reduc
ed
Reduc
ed
20
40
60
More restless &More confused
Less Eager to play &Less Active
Survey of UK Owners with Pets over 7 years old
44
67
53
3331
Introduction CDS Epidemiology Pathology Management Conclusion
However, despite owners being able to see the signs
of Cognitive Dysfunction:Only 7% of owners feel well informed about treatments available for older pet behavioural problems46% are unaware that there are any treatments at allAs a result of this, they may not see the point in seeking advice. Owners fear that euthanasia would be the only recommendation by the vet if no treatments are available.
Survey of UK Owners with Pets over 7 years old
Introduction CDS Epidemiology Pathology Management Conclusion
80% of owners would like more access to information about older pets – 61% would like to attend clinics for older pets
83% of owners would want advice and treatment of pets diagnosed with age related behavioural disorders
Survey of UK Owners with Pets over 7 years old
Introduction CDS Epidemiology Pathology Management Conclusion
Conclusions from UK Survey
Cognitive Dysfunction in the UK seems to effect 30%+ of all pets over 7 years oldThe pet owner is noticing the behavioural changes associated with the conditionMany owners are unaware of available treatments for older pet behaviour problemsThe vast majority want more information, many willing to attend special vet clinics to help their pets
Introduction CDS Epidemiology Pathology Management Conclusion
Cat Cognitive Dysfunction
43% of 152 cats had one or more signs consistent with CDSAfter excluding medical cases
28% of cats aged 11-14 years 49% of cats aged 15-21 years old
Displayed signs consistent with cognitive dysfunctionFor instance,
Does the cat continue to use the little box on a regular basis?
Does the cat continue to groom and show interest in household activities?
Introduction CDS Epidemiology Pathology Management Conclusion
Mitochondrial Energy & Free Radical Production
Introduction CDS Epidemiology Pathology Management Conclusion
End Result = Loss of Grey and White Matter
Effect of Age-Related Brain Damage
Introduction CDS Epidemiology Pathology Management Conclusion
Patho-physiology of Cognitive Dysfunction
Cummings et al 1998 Accumulation of β-amyloid deposits in
frontal and hippocampus in dogs with increased cognitive dysfunction
Almost identical to Alzheimer disease in humans
Cummings et al 1996 Degree of β-amyloid deposits in the dog
brain was proportional to the degree of impairment in learning complex tasks
Introduction CDS Epidemiology Pathology Management Conclusion
Patho-physiology of Cognitive Dysfunction
The decline of neuronal grey and white matter in the frontal and cerebral brainIncrease in ventricular volumeNeurotoxic deposits (lipofuscin, ubiquitin and β-amyloid)Results in
Loss of Memory Loss of Innate Controls
• Bladder• Rectum
Increase in anxiety
Introduction CDS Epidemiology Pathology Management Conclusion
Effects of Gonadectomy on Cognitive Dysfunction
Human research and laboratory research has shown beneficial effects of oestrogen and testosterone for neuron survival and adaptive growth (Haskell et al 1997; Yaffe et al 1998)
Ovariectomy may predispose women to ADHigh correlation with men diagnosed with AD and low levels of free testosterone
Study of aging dogs and cognitive dysfunction: Intact males only showed mild signs of CD Neutered males about 50% showed severe stage CD
behavioural changes (Hart B.L. JAVMA 2001)
Introduction CDS Epidemiology Pathology Management Conclusion
CD Diagnostics
Eliminate other possible causes of age-related behavioural changes
Musculoskeletal Organ failure Endocrinopathies, i.e. thyroid Cardiovascular
Simple CBC and biochemistryUrine testsAsk appropriate behavioural screening questions (DISHA)
Introduction CDS Epidemiology Pathology Management Conclusion
Prevention and Treatment of Age-Related Cognitive Dysfunction
Calorific restriction is the only known regimen of life-style change that increases the life-span of animals
Most important aspects to control are: Maintenance of mitochondrial function Control of oxidant production Production of neurotransmitters
Introduction CDS Epidemiology Pathology Management Conclusion
Prevention and Management of Age-Related Cognitive Dysfunction
Supplementation of diet with specific metabolites:
Metabolic enhancers Neurotransmitter enhancers Antioxidant damage preventers
Drugs i.e. L-deprenyl HCl an MAO B inhibitor
Introduction CDS Epidemiology Pathology Management Conclusion
Management of Cognitive Dysfunction
L-deprenyl HCl (Selegiline) = ameliorates signs of CD in some dogs.
Reduces depletion of dopamine & some neuroprotective and antioxidant support
Numerous drugs contraindicated with its use Side effects in several different trials
Nicergoline (alpha 1&2 adrenergic antagonist) Increase cerebral blood flow, enhance neuronal transmission,
and have a neuroprotective effect
Propentofylline Inhibit platelet aggregation and blood flow
Introduction CDS Epidemiology Pathology Management Conclusion
Supplementation Studies into Reducing Cognitive Dysfunction
SymptomsL-Carnitine and alpha-lipoic acid fed to old rats
Reversed age-related mitochondrial degeneration Lowered oxidative damage in liver cells Increased the binding affinity of brain and memory
related enzymes (Hageb et al 1998; Liu et al 2002)
1 year study in old dogs with L-Carnitine, alpha-lipoic acid, and vitamins E and C supplemented
Significantly reduced the impairment that aged dogs showed on difficult discrimination tasks (Milligram et al 2002 and 2005)
Introduction CDS Epidemiology Pathology Management Conclusion
Supplementation Studies into Reducing Cognitive Dysfunction
Symptoms in the DogMilligram’s study in Beagles tested three groups:
Behavioural enrichment Supplementation Combination of both
Both behavioural enrichment and supplementation reduced age-related declineThe combination had the greater protective effect on learning ability = Synergism
Introduction CDS Epidemiology Pathology Management Conclusion
ConclusionCognitive Dysfunction is recognized as an increasing disorder in the aging pet populationOther age-related diseases need to be ruled out first by a thorough clinical examinationOwners are acutely aware of the change in behaviour of their “older” pets but unaware of viable management and therapeutic optionsOwners reluctant to seek veterinary advice for fear of euthanasia being offeredAdd behavioural questions to your old pet exams
Introduction CDS Epidemiology Pathology Management Conclusion
Drs. Sarah Heath and Paul Craze plus all the UK vets, nurses and dog owners
involved in the Aktivait Trial
Aktivait – BehaviouralAge-related Pet Supplement
Canine Cognitive Dysfunction A Nutritional Supplement TrialCanine Cognitive Dysfunction A Nutritional Supplement Trial
Stephen Barabás BSc BVMS MRCVS1
Hermann FM Bourgeois DVM2
1.VetPlus,Lytham St. Anne’s, UK2 Takamby Consult., Panama St.
Introduction Material Method Results Discussion Conclusion
End Result = Loss of Grey and White Matter
Effect of Age-Related Brain Damage
What Causes Canine Cognitive Dysfunction?
Physiological condition
Compromised cerebral blood flow
Depletion in neurotransmitters: dopamine…
Increased levels of free radicals
Behavioral signs “DISH”
D isorientation
I nteraction
S leep Pattern
H ouse Training
Introduction Material Method Results Discussion Conclusion
Survey at Crufts Dog Show VETPLUS, 2005 n = 981
0 10 20 30 40 50 60 70 80
House Soiling
Restless
Confusion
Eagerness to play
In house activity
Sleeping
Life enjoyment
%
Introduction Material Method Results Discussion Conclusion
Supplementation Canine CD Trial
Objective: To assess the therapeutic effect of a nutritional
supplement including anti-oxidants in the
management of CDD in dogs
Type Multi-centered
• 20 veterinary practices
• Geographically dispersed
• Duration: 56 days
Placebo controlled
Double-blinded
Introduction Material Method Results Discussion Conclusion
Inclusion: Exclusion Criteria
n = 44
Inclusion
> 8 years old
Owner > 2 m
> 1 month “DISH”
Haematology OK
Biochemistry OK
Maintenance diet
Exclusion
Medical treatments
Clinical disease
“DISH” prior to 8 yrs
Prescription diets
Agressivity level
< 1 clinical sign of CD
Introduction Material Method Results Discussion Conclusion
Combination Supplement
Actives (mg) Dogs <10 kg Dogs >10 kg
DHA/EPA 35.0 70.0Vitamin C 20.0 40.0N Acetyl Cysteine 20.0 40.0L-Carnitine 13.5 27.0Alpha lipoic acid 10.0 20.0Vitamin E 10.0 20.0Acetyl L - carnitine 5.0 10.0Co Q10 1.0 2.0Phosphotidylserine 1.0 2.0Selenium (µg) 25 50
Introduction Material Method Results Discussion Conclusion
Oxidative Damage to the Neuron HEAD
E.,2008
Co Q10Vit E, Vit CSeleniumN-acety Cysteïne Lipoic acid
PhosphotidylserineAcetyl L – CarnitineL – carnitineCo Q10
Acetyl L-carnitineL – carnitineCo Q10
EPA/DHAPhosphotidylserine
Introduction Material Method Results Discussion Conclusion
Clinical Methodology
-7 0 10 21 28 42 49
baseline
2
3
1
“exit”
Introduction Mateiral Method Results Discussion Conclusion
BA
Recruitment Criteria: “DISH”
D isorientation Delay or lack of recognition
• people• animals • places
I nteractions social interactions
• people• animals • other pets
display of aggressive behavior
Introduction Material Method Results Discussion Conclusion
S leep Pattern
sleep during daytime
sleep at night
incidence of restlessness during sleep
H ouse Training
incidence of house soiling
inappropriate toileting in a variety of
locations
in sitting at inappropriate doors
Introduction Material Method Results Discussion Conclusion
Recruitment Criteria: “DISH”
Clinical Behaviour Scoring
Referring to baseline – based on differences Insignificant 0
Mild 1
Significant 2
Moderately severe 3
Very severe 4
Semi quantitative Number of incidents
Global owner evaluation
p < 0.05 statistically significant
Introduction Material Method Results Discussion Conclusion
Study Data
End of study 27
Out 17
Placebo 8
Supplement 9
Reasons
Moving
Disrespect of paperwork
Non-relied clinical reasons
Introduction Material Method Results Discussion Conclusion
DisorientationIm
prov
emen
t in
cogn
itive
sc
ore
Days from start of trial
p = 0.040
Introduction Material Method Results Discussion Conclusion
Social Interaction
Days from start of trial
Impr
ovem
nt in
cog
niti
ve
scor
e
p = 0.011
Introduction Material Method Results Discussion Conclusion
Sleep pattern
Days from start of trial
Dai
ly n
o aw
ake
tim
e
p = 0.012
Introduction Material Method Results Discussion Conclusion
Age related behaviour
Days from start of trial
Impr
ovem
nt in
age
rel
ated
be
havi
or
p = 0.020
Introduction Material Method Results Discussion Conclusion
Impr
ovem
nt in
cog
niti
ve
scor
eHouse Soiling
Days from start of trial
p = 0.007
Introduction Material Method Results Discussion Conclusion
Owner Assessment
Days from start of trial
Impr
ovem
nt in
re
lati
onsh
ip
p = 0.014
Introduction Material Method Results Discussion Conclusion
Glo
bal a
sses
men
t sc
oreVet Assessment
p = 0.004
Introduction Material Method Results Discussion Conclusion
Perspectives of the Trial
Number of cases
Gender stratification
Age related benefit?
Cross over
Impact in case of drug therapy ?
Introduction Material Method Results Discussion Conclusion
The combination of supplements in this
Nutraceutical appears to help
in the management of the behavioural clinical
signs of the “old dog syndrome”
+ve Changes in age-related behaviour signs
+ve Perception by owner and vet in dogs’ condition
The combination of supplements in this
Nutraceutical appears to help
in the management of the behavioural clinical
signs of the “old dog syndrome”
+ve Changes in age-related behaviour signs
+ve Perception by owner and vet in dogs’ condition
Introduction Material Method Results Discussion Conclusion